Becton, Dickinson and Company has participated in a round that took the GE Ventures-backed medication analysis technology provider's total funding to $8m.
Israel-based medication surveillance technology developer MedAware secured $8m on Wednesday in a series A round that included medical device maker Becton, Dickinson and Company.
The round also featured fertiliser additive producer Yingcheng City Fubon Technology, investment group Gefen Capital and crowdfunded investment platform OurCrowd.
Founded in 2012, MedAware has created a system that uses machine learning algorithms to detect adverse drug events caused by prescribed medication that could cause harm to a patient. It will use the series A funding…
